Orphan product definition

Orphan product means a mercury-containing light that lacks a producer's brand, or for which the producer is no longer in business and has no successor in interest, or that bears a brand for which the department cannot identify an owner.
Orphan product means a covered electronic product that lacks
Orphan product means a product that lacks a brand, for which the producer is no

More Definitions of Orphan product

Orphan product means a mercury-containing light that lacks
Orphan product means a covered electronic product that lacks a manufacturer's brand or for which the manufacturer is no longer in business and has no successor in interest.
Orphan product means a covered electronic product that lacks a manufacturer's brand or for which the manufacturer is no longer in business and has no successor in interest, or is a brand for which ecology cannot identify an owner.
Orphan product means a pharmaceutical product that (a) satisfies the criteria for orphan drug designation established by the FDA or any other Regulatory Authority in the Territory; and (b) has received Regulatory Approval for an Indication other than an Excluded Orphan Indication.
Orphan product means lighting that contains mercury that lacks a brand, for which
Orphan product means any Patented Product for which orphan designation is approved by the United States FDA and “Non-Orphan Product” shall mean a Patented Product which is not an Orphan Product. “Patented Product” means any Product (i) the selling of which would, in the absence of this Agreement, infringe a valid claim of an issued, unexpired patent within the Licensed Patent Rights in the country in which such Product is sold by Amgen or its affiliate or sublicensee, (ii) with respect to which a market exclusivity period has been granted by a governmental body or regulatory authority and is in effect in the country in which such Product is sold by Amgen or its affiliate or sublicensee, or (iii) with respect to which data exclusivity has been granted by a governmental body or regulatory authority and is in effect in the country in which such Product is sold by Amgen or its affiliate or sublicensee. Such royalties shall be payable on a Patented Product-by-Patented Product and country-by-country basis in the Territory from the date of first commercial sale of a given Patented Product in a given country until the later to occur of (a) expiration of the last to expire of a valid claim of an issued, unexpired patent within the Licensed Patent Rights in the country in which such Patented Product is sold by Amgen or its affiliate or sublicensee, (b) expiration of any market exclusivity period granted by a governmental body or regulatory authority with respect to such Patented Product in such country, or (c) expiration of any data exclusivity period granted by a governmental body or regulatory authority with respect to such Patented Product in such country, and in the case of clause (c) above, only for so long as the total number of units of a Patented Product sold in a calendar quarter exceeds the total number of units of generic products (corresponding to the Patented Product) sold in the same calendar quarter (hereinafter the “Royalty Term”); provided that, with respect to Patented Products which are designated as Orphan Products in the United States, such data exclusivity period shall be deemed to be twelve (12) years from the date of U.S. FDA marketing approval thereof, and that, with respect to Patented Products which are not designated as Orphan Products in the United States, such data exclusivity period shall be deemed to be the data exclusivity period then in effect in the United States at the time of U.S. FDA approval of the applicable Patented Product. For purposes of...
Orphan product means a designated waste for which the producer